{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T21:08:59Z","timestamp":1776805739827,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04281-4","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:14:56Z","timestamp":1759151696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neoadjuvant chemotherapy strategies for optimizing safety and efficacy in elderly patients with locally advanced gastric cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Yoshihiko","family":"Kakiuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Hanzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Kanaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Kashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunitoshi","family":"Shigeyasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"3","key":"4281_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"4281_CR2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ags3.12717","volume":"7","author":"M Tokunaga","year":"2023","unstructured":"Tokunaga M, Kurokawa Y, Fukagawa T, Muro K, Shitara K, Kodera Y, et al. Neoadjuvant chemotherapy for locally advanced gastric cancer in Japan: consensus meeting at the 77th general meeting of the Japanese society of gastroenterological surgery. Ann Gastroenterol Surg. 2023;7(6):856\u201362.","journal-title":"Ann Gastroenterol Surg"},{"issue":"1","key":"4281_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320.","journal-title":"N Engl J Med"},{"issue":"10184","key":"4281_CR4","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet. 2019;393(10184):1948\u201357.","journal-title":"Lancet"},{"issue":"18","key":"4281_CR5","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810\u201320.","journal-title":"N Engl J Med"},{"issue":"9813","key":"4281_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315\u201321.","journal-title":"Lancet"},{"issue":"15","key":"4281_CR7","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1200\/JCO.18.01138","volume":"37","author":"K Yoshida","year":"2019","unstructured":"Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, et al. Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with stage III gastric cancer: interim analysis of JACCRO GC-07, a randomized controlled trial. J Clin Oncol. 2019;37(15):1296\u2013304.","journal-title":"J Clin Oncol"},{"issue":"26","key":"4281_CR8","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1200\/JCO.20.02914","volume":"39","author":"YK Kang","year":"2021","unstructured":"Kang YK, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, et al. Prodigy: a phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer. J Clin Oncol. 2021;39(26):2903\u201313.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4281_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/bjs.9484","volume":"101","author":"A Tsuburaya","year":"2014","unstructured":"Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 2014;101(6):653\u201360.","journal-title":"Br J Surg"},{"issue":"2","key":"4281_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s10120-016-0619-z","volume":"20","author":"S Ito","year":"2017","unstructured":"Ito S, Sano T, Mizusawa J, Takahari D, Katayama H, Katai H, et al. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002. Gastric Cancer. 2017;20(2):322\u201331.","journal-title":"Gastric Cancer"},{"issue":"2","key":"4281_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s10120-020-01136-7","volume":"24","author":"Y Iwasaki","year":"2021","unstructured":"Iwasaki Y, Terashima M, Mizusawa J, Katayama H, Nakamura K, Katai H, et al. Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial. Gastric Cancer. 2021;24(2):492\u2013502.","journal-title":"Gastric Cancer"},{"issue":"5","key":"4281_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/jjco\/hyaa005","volume":"50","author":"M Terashima","year":"2020","unstructured":"Terashima M, Yoshikawa T, Boku N, Ito S, Tsuburaya A, Iwasaki Y, et al. Current status of perioperative chemotherapy for locally advanced gastric cancer and JCOG perspectives. Jpn J Clin Oncol. 2020;50(5):528\u201334.","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"4281_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2217\/fon-2019-0528","volume":"16","author":"Y Sato","year":"2020","unstructured":"Sato Y, Kurokawa Y, Doki Y, Mizusawa J, Tanaka K, Katayama H, et al. A phase II study of preoperative chemotherapy with docetaxel, oxaliplatin and S-1 in gastric cancer with extensive lymph node metastasis (JCOG1704). Future Oncol. 2020;16(4):31\u20138.","journal-title":"Future Oncol"},{"issue":"32","key":"4281_CR14","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.2217\/fon-2023-0605","volume":"19","author":"T Hashimoto","year":"2023","unstructured":"Hashimoto T, Nakayama I, Ohashi M, Mizusawa J, Kawachi H, Kita R, et al. Randomized phase II study comparing neoadjuvant 5-fluorouracil\/oxaliplatin\/docetaxel versus docetaxel\/oxaliplatin\/S-1 for patients with type 4 or large type 3 gastric cancer. Future Oncol. 2023;19(32):2147\u201355.","journal-title":"Future Oncol"},{"issue":"2","key":"4281_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/bjs5.50241","volume":"4","author":"Y Kano","year":"2020","unstructured":"Kano Y, Ohashi M, Ida S, Kumagai K, Sano T, Hiki N, et al. Laparoscopic proximal gastrectomy with double-flap technique versus laparoscopic subtotal gastrectomy for proximal early gastric cancer. BJS Open. 2020;4(2):252\u20139.","journal-title":"BJS Open"},{"issue":"5","key":"4281_CR16","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.21037\/jgo-22-527","volume":"13","author":"Y Kakiuchi","year":"2022","unstructured":"Kakiuchi Y, Kuroda S, Kikuchi S, Kagawa S, Fujiwara T. Prognostic risk factors for postoperative long-term outcomes in elderly stage IA gastric cancer patients. J Gastrointest Oncol. 2022;13(5):2178\u201385.","journal-title":"J Gastrointest Oncol"},{"issue":"5","key":"4281_CR17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s10120-023-01404-2","volume":"26","author":"K Keywani","year":"2023","unstructured":"Keywani K, Borgstein ABJ, Eshuis WJ, Pape M, Versteeg KS, Derks S, et al. Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study. Gastric Cancer. 2023;26(5):763\u201374.","journal-title":"Gastric Cancer"},{"issue":"5","key":"4281_CR18","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s10120-024-01522-5","volume":"27","author":"J Wang","year":"2024","unstructured":"Wang J, Wu Z, de Groot EM, Challine A, Mohammad NH, Mook S, et al. Discontinuation of neoadjuvant therapy does not influence postoperative short-term outcomes in elderly patients (\u2265 70 years) with resectable gastric cancer: a population-based study from the Dutch upper Gastrointestinal cancer audit (DUCA) data. Gastric Cancer. 2024;27(5):1114\u201323.","journal-title":"Gastric Cancer"},{"issue":"12","key":"4281_CR19","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.21873\/anticanres.16769","volume":"43","author":"T Mukoyama","year":"2023","unstructured":"Mukoyama T, Kanaji S, Sawada R, Harada H, Urakawa N, Goto H, et al. Safety and efficacy of neoadjuvant chemotherapy for advanced gastric cancer in elderly patients. Anticancer Res. 2023;43(12):5649\u201356.","journal-title":"Anticancer Res"},{"issue":"2","key":"4281_CR20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1245\/s10434-023-14569-y","volume":"31","author":"K Rawicz-Pruszy\u0144ski","year":"2024","unstructured":"Rawicz-Pruszy\u0144ski K, Endo Y, Tsilimigras DI, Munir MM, Resende V, Kim A, et al. Neoadjuvant chemotherapy improves oncological outcomes and long-term survival among elderly patients with locally advanced gastric cancer: a propensity score matched analysis. Ann Surg Oncol. 2024;31(2):753\u201361.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4281_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-018-1534-z","volume":"17","author":"SB Hu","year":"2019","unstructured":"Hu SB, Liu CH, Wang X, Dong YW, Zhao L, Liu HF, et al. Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer. World J Surg Oncol. 2019;17(1):3.","journal-title":"World J Surg Oncol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04281-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04281-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04281-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:14:57Z","timestamp":1759151697000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04281-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4281"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04281-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This study was approved by the institutional review board (IRB) of Okayama University Hospital (Approval no.2503-014). The study was performed in accordance with the Declaration of Helsinki. The informed consent was obtained from the patients or their families according to the IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethicas approval and consent to participate"}},{"value":"No applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"No authors have any conflicts of interest for this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}}],"article-number":"670"}}